UA101665C2 - Analgesic tolerance or constipation inhibitor - Google Patents

Analgesic tolerance or constipation inhibitor

Info

Publication number
UA101665C2
UA101665C2 UAA201015851A UAA201015851A UA101665C2 UA 101665 C2 UA101665 C2 UA 101665C2 UA A201015851 A UAA201015851 A UA A201015851A UA A201015851 A UAA201015851 A UA A201015851A UA 101665 C2 UA101665 C2 UA 101665C2
Authority
UA
Ukraine
Prior art keywords
opioid
constipation
inhibitor
analgesic
analgesic tolerance
Prior art date
Application number
UAA201015851A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джун Оучи
Шунджи Кунори
Йозо Коджима
Кацуми Шинода
Кацутоши Сасаки
Широ Ширакура
Original Assignee
Киова Хакко Кирин Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Киова Хакко Кирин Ко., Лтд. filed Critical Киова Хакко Кирин Ко., Лтд.
Priority claimed from PCT/JP2009/059845 external-priority patent/WO2009145289A1/en
Publication of UA101665C2 publication Critical patent/UA101665C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is an agent for inhibiting an undesirable activity of an opioid-type analgesic agent (opioid), which comprises a compound having an antagonistic activity on an adenosine Areceptor or a pharmaceutically acceptable salt thereof as an active ingredient. The undesirable activity of the opioid-type analgesic agent (opioid) may be analgesic tolerance or constipation. The undesirable activity of the opioid-type analgesic agent (opioid) may be analgesic tolerance.
UAA201015851A 2008-05-29 2009-05-29 Analgesic tolerance or constipation inhibitor UA101665C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008141178 2008-05-29
PCT/JP2009/059845 WO2009145289A1 (en) 2008-05-29 2009-05-29 Inhibitor of analgesic tolerance

Publications (1)

Publication Number Publication Date
UA101665C2 true UA101665C2 (en) 2013-04-25

Family

ID=51950346

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201015851A UA101665C2 (en) 2008-05-29 2009-05-29 Analgesic tolerance or constipation inhibitor

Country Status (1)

Country Link
UA (1) UA101665C2 (en)

Similar Documents

Publication Publication Date Title
EA201071395A1 (en) TOLERANCE INHIBITOR TO ANALGETICS
PH12014502721A1 (en) IMIDAZO[1,2-b] PYRIDAZINE DERIVATIVES AS KINASE INHIBITORS
HK1154002A1 (en) Imidazopyridazinecarbonitriles useful as kinase inhibitors
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
WO2014151871A3 (en) Jak2 and alk2 inhibitors and methods for their use
MX2009008540A (en) Pyrimidine substituted macrocyclic hcv inhibitors.
MX2010004232A (en) Pyrimidyl indoline compound.
WO2008096001A8 (en) Hcv inhibiting macrocyclic phenylcarbamates
WO2008033798A3 (en) A pyrrolopyrazin as syk-kinase inhibitor
TW200612958A (en) Substituted imidazole derivatives
TN2011000222A1 (en) Melanocortin receptor agonists
EP2288260A4 (en) Triazolopyridine jak inhibitor compounds and methods
WO2009024889A3 (en) Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe
MX336271B (en) Triazolopyridine jak inhibitor compounds and methods.
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors
TNSN08191A1 (en) Kinase inhibitors
MX2009007260A (en) Cyclized derivatives as eg-5 inhibitors.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
MX2009005071A (en) Substituted pyrazole and triazole compounds as ksp inhibitors.
WO2010031832A3 (en) Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative
TN2012000092A1 (en) Therapeutic agent for mood disorders
WO2009041663A1 (en) Agent for prevention and/or treatment of skin diseases
WO2010130773A3 (en) Benzoxazolone derivatives as aldosterone symthase inhibitors
NZ592927A (en) PHOSPHODIESTERASE TYPE III (PDE III) INHIBITORS OR CA2+-SENSITIZING AGENTS such as pimobendan FOR THE TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
WO2009051223A1 (en) Pharmaceutical composition for treatment of cataract